Fixed and autoadjusting continuous positive airway pressure treatments are not similar in reducing cardiovascular risk factors in patients with obstructive sleep apnea
Background A strong association between obstructive sleep apnea (OSA) and the risk for
cardiovascular and cerebrovascular diseases has been reported. Continuous positive
airway pressure (CPAP) is the first-line therapy for OSA, able not only to reduce daytime
sleepiness but also to improve cardiovascular and metabolic outcomes. Autoadjusting
CPAP (APAP), an alternative treatment to CPAP, can reduce OSA symptoms while
increasing long-term CPAP compliance without the high costs of CPAP titration. However …
cardiovascular and cerebrovascular diseases has been reported. Continuous positive
airway pressure (CPAP) is the first-line therapy for OSA, able not only to reduce daytime
sleepiness but also to improve cardiovascular and metabolic outcomes. Autoadjusting
CPAP (APAP), an alternative treatment to CPAP, can reduce OSA symptoms while
increasing long-term CPAP compliance without the high costs of CPAP titration. However …